Cochrane looking for feedback on how they plan, do, and share the results of rapid reviews

Andy · Oct 30, 2020

In case anybody is interested.

WHAT IS THIS SURVEY ABOUT?
This survey is the first stage of the Priority III project. This project will identify the current most important research questions on how we bring together and summarise information from lots of different research studies, using an approach called a 'rapid review’.

WHAT EXACTLY DO WE MEAN BY A ‘RAPID REVIEW'?

A rapid review is a type of evidence synthesis that brings together and summarises information from lots of different research studies to produce evidence for people such as the public, researchers, policy makers and funders in a systematic, resource-efficient manner. This is done by speeding up the ways we plan, do, and/or share the results of conventional structured (systematic) reviews, by simplifying or omitting a variety of methods that should be clearly defined by the authors.

The rapid reviews that we refer to in this study are done in relation to healthcare.
Click to expand...

https://priority3.questionpro.eu/

https://twitter.com/user/status/1322103205032067073

Snowdrop · Oct 30, 2020

I know nothing about how this sort of thing is done but am immediately led to wonder (because of what I have read and know about Cochrane) if firstly, the questions they ask will not be the kind that would be useful and if the very idea really of a rapid response is part of the problem in the first place. Dumbing everything down til it says nothing useful.

Will be happy to be mistaken here.

Sly Saint · Oct 31, 2020

WHO IS RUNNING THIS SURVEY?
This survey comes to you from the Rapid Review Methodology Priority Setting Partnership (PSP). Our project brings together the public, reviewers, researchers, funders, policymakers, and clinicians from across the world to agree on a 'Top-10' list of the most important questions about how we plan, do and share the results of rapid reviews.

This research is being conducted by Evidence Synthesis Ireland and the James Lind Alliance (UK). The Priority III study is being funded by the Health Research Board (HRB) and the Health and Social Care division of the Public Health Agency (PHA) of Northern Ireland within Evidence Synthesis Ireland (ESI).
Click to expand...

WHO SHOULD TAKE PART?
The findings of rapid reviews are used in healthcare decisions and therefore have the potential to impact all of our lives. We invite patients, members of the public, reviewers, researchers, clinicians, policymakers, and funders who are over 18 years of age to take part in this survey. Participants do not need to have any research experience or previous involvement in a rapid review.Due to the unavailability of translation services, you must also have a competent level of fluency in English to take part in the study.
Click to expand...

Please be aware that this SURVEY WILL CLOSE ON WEDNESDAY, 4TH NOVEMBER 2020

eta: I just did it. You don't have to give your name or any details.

Log in or Sign up

Cochrane looking for feedback on how they plan, do, and share the results of rapid reviews

Andy Committee Member

Snowdrop Senior Member (Voting Rights)

Sly Saint Senior Member (Voting Rights)

Share This Page

Log in or Sign up

Cochrane looking for feedback on how they plan, do, and share the results of rapid reviews

Andy Committee Member

Snowdrop Senior Member (Voting Rights)

Sly Saint Senior Member (Voting Rights)

Share This Page

Useful Searches